Australian researchers leading the way for a rare ovarian cancer.

Australian researchers at the Hudson Institute of Medical Research are leading the way for Granulosa Cell Tumour (GCT), a rare ovarian cancer. The researchers have an opportunity to undertake enhanced DNA testing called Whole Genome Sequencing (WGS) that could hold the answers for both subtypes of GCT adult GCT and Juvenile GCT.

ROC Inc. aim is to raise the $30,000 needed to help get this testing underway. With no effective treatments for this recurrent cancer, we need to act now to save lives.

Every dollar you can contribute counts.

Donation Page

Donate now or start your own fundraiser or team.

  1. Changing Lives Through Ovarian Cancer Research – Main Campaign

    All Fundraisers and Team totals contribute to this campaign
    $11,419.95 donated of $30,000.00 goal
Posted in Updates and tagged , , , , .